The Intermountain Healthcare Heart Institute research team are presenting or involved in 20 posters and abstracts at the American Heart Association’s Scientific Sessions in Philadelphia, Nov. 16-18, 2019. Topics range from heart health and intermittent fasting to precision medicine in cardiology. Our cardiovascular researchers are also serving as panelists or giving presentations focused on improving patient care.

Abstracts and Posters

  • COLLABORATIVE POSTER: Clinical Value of Neutrophil to Lymphocyte Ratio and its Trajectory in Patients Hospitalized with Acute Heart Failure and Preserved Ejection Fraction (Kirk U. Knowlton, MD)
  • POSTER: Evaluation of Treatment with Angiotensin Converting Enzyme Inhibitors (ACEIs) and the Risk of Lung Cancer (ERACER) (Jeffrey L. Anderson, MD)
  • POSTER: Use of the AHA Pegasis Pipeline to Identify Genetic Associations with Severe 3-Vessel Coronary Artery Disease in High-Risk Pedigrees Free from Myocardial Infarction: The ProGENE Study (Stacey Knight, PhD)
  • COLLABORATIVE ORAL POSTER: Intermittent Fasting Lifestyle and Incidence of Heart Failure and Myocardial Infarction in Cardiac Catheterization Patients (Benjamin Horne, PhD)
  • POSTER: Predictive Ability of Machine Learning Models for High-Grade Coronary Artery Disease Using Free Fatty-Acid Metabolites (Raymond O. McCubrey, MD)
  • COLLABORATIVE POSTER: Precision Cardiovascular Medicine: A Rapid and Highly Sensitive Artificial Intelligence-based Integrated Genetic-Epigenetic DNA Test for 3-Year Risk for Incident Coronary Heart Disease (Stacey Knight, PhD)
  • POSTER: Intermittent Fasting Lifestyle and Human Longevity in Cardiac Catherization Populations (Benjamin Horne, PhD)
  • POSTER: The HyperK Score is a Powerful Predictor of Incident Hyperkalemia in a Large General Healthcare Population (Heidi T. May, PhD)
  • MODERATED POSTER: Comparative 5-year Outcomes in Non-ischemic Dilated Cardiomyopathy (NIDC) Patients with TITIN (TTN) Gene Truncating Variant (tv) Mutations (Jeffrey L. Anderson, MD)
  • POSTER: Long-Term Outcomes in Patients Treated with Flecainide for Premature Ventricular Contractions or Ventricular Tachycardia with Stable Coronary Artery Disease (T. Jared Bunch, MD)
  • POSTER: Long-Term Outcomes in Patients Treated with Flecainide for Atrial Fibrillation with Severe Coronary Artery Disease Treated with Revascularization (T. Jared Bunch, MD)
  • POSTER: Laboratory-based Intermountain Risk Score Compared to the Charlson and Elixhauser Comorbidity Indices for Mortality Prediction (Benjamin Horne, PhD)
  • POSTER: Use of Precision Behavioral Nudges to Modify Patient Choice Architecture: The ImprovEment in MedicatioN AdherenCe ThrOUgh the Implementation of PeRsonAlized NudGEs (ENCOURAGE) Randomized Controlled Trial (Benjamin Horne, PhD)
  • POSTER: Higher Plasma EPA, EPA/AA and DHA Levels are Associated with Lower Incident MACE in Those with and without Angiographic CAD (Viet Le, APP)
  • POSTER: Does Supplementation to Higher Plasma Omega-3 Levels Predispose to Prostate Cancer? Results from the Intermountain INSPIRE Biobank Registry (Jeffrey L. Anderson, MD)
  • POSTER: Skewness but Not Kurtosis of Red Cell Corpuscular Volume Nullifies the Predictive Ability of Red Cell Distribution Width for Predicting All-Cause Mortality (Benjamin Horne, PhD)
  • ORAL ABSTRACT: Temporal Changes in Statin Prescription, Intensity at Discharge, and Impact on Outcomes in Patients with Newly Diagnosed Atherosclerotic Peripheral Arterial Disease (PAD). A Real-World Experience within a Large Integrated Health Care System: The IMPRESS Study (Jeffrey L. Anderson, MD)
  • PRESENTATION: Catheter Ablation and Brain Injury: Implications for Dementia Prevention (T. Jared Bunch, MD)
  • PRESENTATION: AF and Dementia: Potential Mechanisms and Implications for Prevention (T. Jared Bunch, MD)
  • ORAL ABSTRACT: Long-Term Outcomes in Patients with Flecainide for Atrial Fibrillation with Stable Coronary Artery Disease (T. Jared Bunch, MD)
  • POSTER: Frequency and Clinical Impact of Hyperkalemia within a Large General Population of Heart Failure Patients (J. Brent Muhlestein, MD)
  • POSTER: Difference in Primary Prevention Recommendations for Statin Theraphy Based on National Guidelines Using the Pooled Cohort Equation Risk Versus the Coronary Artery Calcium Score: Preliminary Findings from the Vanguard Study for the CorCal Randomized Clinical Outcomes Trial (J. Brent Muhlestein, MD)